If you are unable to see this message, click here to view it in a web browser.

Justia Daily Opinion Summaries

Utah Supreme Court
April 27, 2020

Table of Contents

Davis County v. Purdue Pharma, LP

Drugs & Biotech

COVID-19 Updates: Law & Legal Resources Related to Coronavirus

Click here to remove Verdict from subsequent Justia newsletter(s).

New on Verdict

Legal Analysis and Commentary

Rethinking Retroactivity in Light of the Supreme Court’s Jury Unanimity Requirement

MICHAEL C. DORF

verdict post

In light of the U.S. Supreme Court’s decision Monday in Ramos v. Louisiana, in which it held that the federal Constitution forbids states from convicting defendants except by a unanimous jury, Cornell law professor Michael C. Dorf discusses the Court’s jurisprudence on retroactivity. Dorf highlights some costs and benefits of retroactivity and argues that the Court’s refusal to issue advisory opinions limits its ability to resolve retroactivity questions in a way that responds to all the relevant considerations.

Read More

Utah Supreme Court Opinions

Davis County v. Purdue Pharma, LP

Citation: 2020 UT 17

Opinion Date: April 23, 2020

Judge: Thomas R. Lee

Areas of Law: Drugs & Biotech

In this case, one of thousands filed by state and local governments against opioid manufacturers across the country, the Supreme Court affirmed the judgment of the second district court granting a manufacturer defendant's motion to transfer the Davis County action to the third district court for discovery and pretrial proceedings, holding that the district court did not abuse its discretion. Plaintiffs in these cases asserted that manufacturers and distributors of opioid drugs misled the public about the safety of these drugs, leading to the opioid epidemic. Fifteen opioid cases were filed in Utah courts. When certain manufacturer defendants moved to consolidate all of the state's pending cases in third district, the court invited judges in other district courts to consider transferring their opioid cases to the third district. Janssen Pharmaceuticals, Inc. filed a motion in the second district asking that the court transfer the Davis County action to the third district for discovery and pretrial proceedings. The second district granted the transfer petition. The Supreme Court affirmed, holding (1) the district court has inherent authority to grant a motion to transfer for pretrial proceedings; and (2) the district court did not exceed the bounds of its discretion in transferring this case to the third district.

Read Opinion

Are you a lawyer? Annotate this case.

About Justia Opinion Summaries

Justia Daily Opinion Summaries is a free service, with 68 different newsletters, covering every federal appellate court and the highest courts of all US states.

Justia also provides weekly practice area newsletters in 63 different practice areas.

All daily and weekly Justia newsletters are free. Subscribe or modify your newsletter subscription preferences at daily.justia.com.

You may freely redistribute this email in whole.

About Justia

Justia is an online platform that provides the community with open access to the law, legal information, and lawyers.

Justia

Contact Us| Privacy Policy

Unsubscribe From This Newsletter

or
unsubscribe from all Justia newsletters immediately here.

Facebook Twitter LinkedIn Justia

Justia | 1380 Pear Ave #2B, Mountain View, CA 94043